CRZN Financial Statements & Analysis
Complete financial statements for CRZN including income statement, balance sheet, and cash flow statement. Analyze CRZN's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).
Financial Health Score
Financial Health Score
Income Statement
Revenue
0.0% ↓
Net Income
49146234.7% ↑
Gross Margin
0.0% ↓
Operating Margin
0.0% ↓
Balance Sheet
Current Ratio
-22.9% ↓
Debt to Equity
0.0% ↓
Asset Turnover
0.0% ↓
Cash Flow
Operating Cash Flow
14.1% ↑
Net Cash Flow
26.5% ↑
Free Cash Flow
14.1% ↑
Cash Flow to Debt
14.1% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | TTM Q3 '22 | TTM Q4 '22 | Change | Impact |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0.0% | |
| Gross Profit | 0 | 0 | 0.0% | |
| Operating Income | -986.00K | 358.76M | 36485.1% | |
| Net Income | 19.75M | 9.70T | 49146234.7% | |
| EPS | 0.19 | 97676.81 | 50406397.2% | |
| EBITDA | 2.27M | 358.76M | 15683.4% | |
| Gross Margin | 0.00% | 0.00% | 0.0% | |
| Operating Margin | 0.00% | 0.00% | 0.0% | |
| Net Income Margin | 0.00% | 0.00% | 0.0% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | TTM Q4 '22 | TTM Q3 '22 | TTM Q2 '22 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Income | 358.76M | -986.00K | -1.04M |
| Net Income | 9.70T | 19.75M | 16.09M |
| EPS | 97676.81 | 0.19 | 0.16 |
| EBITDA | 358.76M | 2.27M | 2.22M |
| Gross Margin | 0.00% | 0.00% | 0.00% |
| Operating Margin | 0.00% | 0.00% | 0.00% |
| Net Income Margin | 0.00% | 0.00% | 0.00% |
| R&D Expenses | 0 | 0 | 0 |
Financial Metrics
Want to dive deeper into CRZN's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics